Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Bacterial pathogens associated with diabetic foot ulcers" is a descriptive term for the wide range of bacterial species—often both Gram-positive (such as *Staphylococcus aureus*, including MRSA, and streptococci) and Gram-negative (such as *Pseudomonas aeruginosa*, *Escherichia coli*, *Klebsiella pneumoniae*, and *Proteus* spp.)—that are commonly isolated from infected diabetic foot ulcers. These infections are frequently polymicrobial (caused by multiple bacteria), sometimes include anaerobic bacteria and fungi, and are associated with increased risk of limb amputation and therapeutic challenges due to high rates of antibiotic resistance. These are not canonical molecular targets in the usual sense of drug discovery but are instead clinical microbiological entities that guide the selection of antimicrobial therapy.
Inhibition of bacterial cell wall synthesis, Inhibition of protein synthesis, Inhibition of nucleic acid synthesis, Disruption of bacterial membranes, β-lactamase inhibition
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial pathogen associated with diabetic foot ulcer.